Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Return on Assets (2022 - 2025)

Historic Return on Assets for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to 1.02%.

  • Orchestra BioMed Holdings' Return on Assets fell 2600.0% to 1.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.02%, marking a year-over-year decrease of 2600.0%. This contributed to the annual value of 0.71% for FY2024, which is 2100.0% down from last year.
  • As of Q3 2025, Orchestra BioMed Holdings' Return on Assets stood at 1.02%, which was down 2600.0% from 1.37% recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Return on Assets ranged from a high of 0.34% in Q1 2023 and a low of 1.37% during Q2 2025
  • For the 4-year period, Orchestra BioMed Holdings' Return on Assets averaged around 0.68%, with its median value being 0.64% (2024).
  • Per our database at Business Quant, Orchestra BioMed Holdings' Return on Assets tumbled by -700bps in 2023 and then plummeted by -6700bps in 2025.
  • Over the past 4 years, Orchestra BioMed Holdings' Return on Assets (Quarter) stood at 0.4% in 2022, then decreased by -18bps to 0.47% in 2023, then tumbled by -72bps to 0.8% in 2024, then fell by -26bps to 1.02% in 2025.
  • Its Return on Assets was 1.02% in Q3 2025, compared to 1.37% in Q2 2025 and 0.98% in Q1 2025.